scispace - formally typeset
M

Mehri Faghihi

Researcher at Isfahan University of Medical Sciences

Publications -  7
Citations -  123

Mehri Faghihi is an academic researcher from Isfahan University of Medical Sciences. The author has contributed to research in topics: Cancer & Breast cancer. The author has an hindex of 5, co-authored 7 publications receiving 118 citations.

Papers
More filters
Journal ArticleDOI

Indoor women jobs and pulmonary risks in rural areas of Isfahan, Iran, 2000

TL;DR: In this paper, the authors evaluated the role of indoor duties in the prevalence of asthma, chronic bronchitis, and related symptoms among females in Isfahan suburbs and found that women doing indoor jobs are potential risk factors for development of chronic obstructive pulmonary disease.
Journal ArticleDOI

Early effects of burning rice farm residues on respiratory symptoms of villagers in suburbs of Isfahan, Iran.

TL;DR: Study findings suggest increased respiratory morbidity associated with rice burning episodes among all people living in the area and suggest smoke-induced air pollution may affect respiratory health further.
Journal ArticleDOI

Common causes of pleural effusion in referral hospital in Isfahan, Iran 1997-1998.

TL;DR: Pleural effusions are frequent in Iran, and the causes are fairly similar to those reported by European authors, but with slightly more tuberculosis cases, mostly among Afghan refugees.
Journal ArticleDOI

Hormonal and reproductive risk factors associated with breast cancer in Isfahan patients.

TL;DR: Compared with other studies, there was not seen any significant relationship between age, vocation, and marital status with odds of breast cancer in multiple model, and use of OCPs as protective factor, hormone replacement therapy, and menopause at old age are identified as the risk factors in developing breast cancer among women.
Journal ArticleDOI

The expression of prostate-specific antigen in invasive breast carcinoma and its relationship with routine clinicopathologic parameters

TL;DR: The detection of PSA by immunohistochemistry does not seem to be a significant prognostic parameter in patients with invasive breast carcinoma, and its relationship with routine clinicopathologic parameters is unclear.